










































In multicellular organisms, specificity of cell types is 
maintained by mitotically heritable differences in gene 
expression, which are in part regulated by epigenetic 
mechanisms. These include RNA-based mechanisms, 
histone modifications, and DNA methylation [1]. The 
full range of epigenetic marks is currently unknown but 
is potentially enormous, considering that the diploid 
human epigenome contains >108 Cytosines (of which 













































DNA methylation is one of the best understood 
epigenetic modification and has an important role in 
several biological processes such as genome imprinting, 
defence against viral sequences, inhibition of 
recombination, as well as assembly of heterochromatin 
[2]. 
 
Aberrant DNA methylation patterns have been linked 
to genomic instability and increased mutation rates 
[3,4]. The role of DNA methylation has been mainly 
explored in the context of cancer [5,6]. Findings from 
these studies have extensively demonstrated that 























mutations  (SEMs)  and  aging.  We  analysed  methylation  levels  through  the  Infinium  HumanMethylation27  and
HumanMethylation450  BeadChips  in  a  population  of  178  subjects  ranging  from  3  to  106  years.  For  each  CpG  probe,
epimutated  subjects were  identified as  the extreme outliers with methylation  level exceeding  three  times  interquartile
ranges the first quartile (Q1‐(3 x IQR)) or the third quartile (Q3+(3 x IQR)). We demonstrated that the number of SEMs was
low  in  childhood  and  increased  exponentially  during  aging.  Using  the  HUMARA  method,  skewing  of  X  chromosome
inactivation (XCI) was evaluated in heterozygotes women. Multivariate analysis indicated a significant correlation between
log(SEMs) and degree of XCI skewing after adjustment for age (β = 0.41; confidence interval: 0.14, 0.68; p‐value = 0.0053).
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cancer development is associated with gain of DNA 
methylation at CpG islands, loss-of-imprinting and 
epigenetic remodeling of repeat elements [7]. 
Interestingly, altered DNA methylation seems to be 
involved in the pathogenesis of other age-related 
diseases, such as cardiovascular, neurological and 
metabolic disorders, and autoimmune diseases [8]. 
 
Recently published papers also demonstrate that DNA 
methylation patterns are not static and they naturally 
change with aging in a complex manner. The 
biological meaning of these changes remain to be 
elucidated although many authors suggest that aging-
associated epigenetic modifications may play a central 
role in the development of several age-related diseases 
[9,10].  
  
Several studies analysed the DNA methylation status in 
groups of subjects going from childhood to centenarian 
age through a genome-wide approach and reported an 
age-related decrease in global DNA methylation [11–
13]. Important insights have also been gained regarding 
the genes showing promoter hyper- or hypomethylation 
as function of age [13–18]. 
 
Age-associated hypermethylation preferentially affects 
loci at CpG islands and genes involved in 
developmental functions and in the control of 
metabolism [13,19]. Conversely, hypomethylation 
seems to mainly involve repetitive elements like Alu 
sequences [13].  
 
Technologies able to investigate the epigenetic profile 
have recently reached the stage at which large-scale 
studies are becoming feasible. Next Generation 
Sequencing can be considered the future challenge, 
although array-based methods actually represent the 
most suitable and cheap devices for genome wide 
epigenetic studies. The increasing interest in 
epigenome-wide association studies (EWASs) has 
supported the development of a growing number of 
analytical tools and packages for the analysis of array 
methylation data [14,20–25]. 
 
Usually, after quality control step and normalisation of 
the dataset, mean methylation levels are calculated for 
each CpG site and are compared between groups of 
subjects in order to identify significant differences or 
correlations. This approach is useful and powerful to 
identify epigenetic alterations shared by a group of 
subjects and potentially associated with their phenotype. 
It provides a general overview of the effect size but 
does not reflect differences in variances or other 
features of the methylation spectrum.  
Rare or stochastic epimutations that are not shared 
among subjects and that minimally affect the mean 
methylation level of the group remain unexplored, 
although they may play a role in phenotype 
development. Furthermore, an analytical strategy 
based on comparisons of mean methylation values 
does not allow to process data obtained from single 
subjects. 
 
As an example, studies on aging well depicted common 
epigenetic modifications associated to the aging 
process, however there is still a lack of knowledge 
regarding the rate of epigenetic mutations that 
stochastically arise on the genome and that are not 
shared among subjects. 
 
To investigate this issue we propose herein a different 
analytical approach that allows to identify stochastic 
epigenetic mutation (SEMs) not shared among subjects. 
We applied this analytical strategy to investigate the 
relations between stochastic epigenetic alteration and 
aging. Furthermore, we studied the relation between 
SEMs and age-dependent skewing of X chromosome 
inactivation that represents a phenomenon favoring the 
expression of multiple deleterious alleles and 




Overall DNA methylation is correlated with age and 
BMI 
 
Methylation levels of 25.014 CpG sites were evaluated 
in whole blood from 170 subjects ranging from 3 to 106 
years. A first descriptive evaluation of the methylation 
status was performed using the Principal Component 
Analysis (Supplemental Figure 1). This analysis 
excluded the presence of samples with aberrant 
epigenetic profiles and the presence of clusters of 
samples carrying peculiar epigenetic features. Subjects 
were then grouped in 5 age ranges (0-19 years, 20-39 
years, 40-59 years, 60-79 years, 80-106 years) including 
at least 10 subjects in each age range. 
 
As shown in Figure 1A, global DNA methylation β 
levels progressively decreased with age and were 
inversely correlated with aging (β = -0.36; confidence 
interval = -0.48, -0.22; p-value = 1.43 x 10-6). 
Moreover, a significant progressive decrease in overall 
DNA methylation levels was also associated with BMI, 
as shown by the density plot in Figure 1B. Indeed, DNA 
methylation was inversely correlated with BMI also 
after adjustment for age (β = -0.19642; confidence 
interval: -0.37, -0.02; p-value < 0.05). 
  



















































































































extreme outliers  samples. For each  sample epimutations are detected,  counted and mapped considering
their genomic position. 
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The number of epimutations increases exponentially 
during aging 
 
The distribution and variability of methylation levels 
were studied for each one of the 25.014 CpG sites using 
Box-and-whiskers plots (Figure 2) as described in the 
materials and methods section. This allowed to obtain 
the total number of SEMs for each subject.  
 
As shown in Figure 3A, considering age ranges, the 
mean number of SEMs increased exponentially during 
aging. 
 
SEMs data were not normally distributed and thus were 
logarithmic transformed before regression analysis. A 







































was evident (η = 0.92) (Figure 3B). This correlation was 
still significant when the subjects were not grouped in 
age ranges but considered individually (r = 0.63; 
confidence interval: 0.53, 0.71; p-value = 2.2 x 10-
16)(Figure 3C).  
 
The density plot in Figure 3D shows the age dependent 
shift in SEMs frequency depending on age range. 
 
Multivariate analysis performed considering log(SEM), 
overall DNA methylation levels, BMI and aging 
confirmed that these findings were not influenced by the 
overall DNA methylation levels. Interestingly, no 
significant correlation between log(SEMs) and BMI 











































log(SEM)  value.  (C)  Linear  correlation  between  age  log(SEM)  considering  all  samples  independently.  (D)
Density plot describing age dependent shift in log(SEM). 
  














The number of SEMs is correlated with skewing of 
X chromosome inactivation 
 
Using the HUMARA method, skewing of X 
chromosome inactivation (XCI) was evaluated in a 
subset of 45 heterozygous women. Multivariate analysis 
indicated a significant correlation between log(SEM) 
and degree of XCI after adjustment for age (β = 0.41; 
confidence interval: 0.14, 0.68; p-value = 0.0053).  
  
Subsequently, we performed a PATH analysis using 
the not imputed original dataset to test the complete 
model containing the variables skewing of XCI, age, 
log(SEMs) and overall CpG methylation in order to 
understand the relations between them. After adjusting 
for the number of epimutations, the marginal 
correlation between skewing of XCI and aging was not 
significant yet. Figure 4 shows the path with the 
respective standardized coefficients.  Similar results 
were obtained also using and combining the five 




Recent findings demonstrate that age associated 
epigenetic modifications involve specific array of genes 
that become hyper or hypo-methylated [11–16]. 
 
In addition to this common epigenetic drift that involves 
specific loci and is shared among old subjects, there are 
also stochastic epigenetic mutations that arise randomly 
in the genome and that are not shared among subjects. 
The somatic mutation theory of aging claims that 
accumulation of stochastic mutations in somatic cells 
results in a decrease of cellular functions [27] and plays 
an important role in aging and in several age-related 
diseases. Ong et al. recently reported a massive increase 
in variably methylated region with age and in regions of 
the genome associated with open chromatin and 
neurotransmission [21].  However, to date there are no 















In the present study we investigated this specific topic 
with a new analytical strategy. Briefly, in a population 
of normal subjects we estimated, for each locus, the 
normal methylation range. This allowed us to identify 
epimutations when the methylation value of a subject 
exceeded the normal range and was extremely far from 
that of the other subjects. We validated this type of 
analysis using duplicated samples and samples with 
well-known and previously reported epigenetic 
alteration. 
 
Using this analytical approach, we report for the first 
time that the number of SEMs is low in childhood and 
increases exponentially during aging. It is highly 
variable among individuals but the correlation between 
log(SEMs) and age is extremely strong. These findings 
lead to speculate that SEMs might have a predictive 
value for aging and could be used as an index of the 
biological age.  
 
We also confirmed that overall DNA methylation level 
decreases during aging and observed that, 
independently of age, BMI can influence DNA 
methylation. These data are in line with previous studies 
reporting an inverse correlation between BMI and 
LINE-1 methylation [28]. In contrast, no association 
between BMI and the number of SEMs was detected. 
This observation is worth noting and unexpected if 
considering the association between BMI and food 
intake that, by itself, can deeply influence DNA 
methylation [29–31]. Finally, we investigated the 
relationship between the number of SEMs and XCI 
skewing. This phenomenon is considered a natural 
consequence of aging [32] and it has been reported to be 
associated with several age-related diseases [33–38]. 
Moreover, recent findings suggest that XCI skewing 
might also influence human longevity and life span 
[26]. 
 
We have described a significant correlation between 
XCI skewing and the number of observed SEM. 






www.impactaging.com                     572                                        AGING,  August 2015, Vol. 7 No.8
skewing, previously reported in other studies [32,39,40] 
did not remain significant when the number of SEMs 
was considered as a covariate. These results may 
suggest for the first time that XCI skewing may not be a 
direct consequence of aging. Indeed, this phenomenon 
has been recently widely debated. Some studies have 
proposed that it could be the result of a clonal stochastic 
loss of haematopoietic cells [36,41] or of a competitive 
advantage for haematopoietic stem cells with a specific 
genotype [42]. The data presented herein support this 
hypothesis leading to speculate that an increased 
number of SEMs might influence haematopoietic stem 
cells viability or might create conditions able to induce 
clonal stochastic loss of a specific type of 
haematopoietic cells.  
 
We acknowledge that the present study has few 
limitations: 
 
1) Only DNA from blood cells was analyzed and, thus, 
additional studies on other tissues are mandatory to 
confirm these preliminary observations.  
2) The phenotypic data of the subjects studied are rather 
scanty. Future studies based on a detailed phenotypic 
characterization may better investigate the effect of 
SEMs on human health and confirm their role as a 
predictor of human aging and healthy aging. 
3) The number of subjects enrolled is consistent, but we 
must underline that a larger sample size could better 
estimate normal ranges of DNA methylation for each 
locus.  
 
In conclusion, the analytical approach presented herein 
might be useful to identify for each subject of a 
population the pattern of epimutations that could have a 
role in determining his phenotype. Moreover, we report 
for the first time that the number of SEMs increase 
exponentially during aging. This observation might be 
used as a predictor of aging and might have important 
implications in future. Finally, we present evidence 
suggesting that the known association between XCI 





Study population. We enrolled a total number of 178 
subjects spanning from 3 to 106 years selected from 
Istituto Auxologico Italiano Biobank. In order to better 
estimate epimutations frequency we identified 5 age 
ranges (0-19 years, 20-39 years, 40-59 years, 60-79 
years, 80-106 years), enrolling at least 10 subjects for 
each age range. An histogram of age and BMI 
distribution of subjects is shown in Supplemental Figure 
2. 
Subjects with imprinting disorders, emathological 
cancers, immune diseases were excluded from the 
study. The study protocol was approved by the Ethical 
Committee of the Istituto Auxologico Italiano. 
 
DNA extraction and bisulphite treatment of the DNA. 
Genomic DNA was extracted from peripheral blood 
using the Wizard genomic DNA purification kit 
(PROMEGA, Madison WI, USA). Samples were 
processed for DNA isolation as follows: 3 to 5 mL of 
blood were lysed with lysis solution provided, digested 
with proteinase K in sodium dodecyl sulfate (SDS) 
buffer at 37°C for 1 hours, then DNA was extracted by 
salting-out, and resuspended in Tris- EDTA (TE) 
buffer. Sodium bisulphite conversion of DNA (500 ng) 
was performed by the EZ DNA Methylation-Gold Kit 
(Zymo Research Corporation, Orange, CA) according to 
the manufacturer’s protocol. 
 
Quality control and quantification of DNA were 
performed before and after bisulphite conversion. DNA 
was quantified with NanoDrop (NanoDrop Products 
Thermo Scientific Wilmington, DE) and quality was 
assessed by visualisation of genomic DNA on 1% 
agarose gel electrophoresis. Only DNA samples not 
fragmented were subsequently processed. 
 
Genome-wide methylation analyses. Whole-genome 
methylation analysis of the DNA from 178 subjects was 
performed using the Illumina Infinium Methylation 
Platform (Illumina, San Diego, CA). 94 samples were 
analysed using the Infinium HumanMethylation 450K 
BeadChip while 84 samples were analysed using the 
27K BeadChip. Those chips allow to assess the 
methylation level of 485,764 and 27,578 CpG sites over 
the entire genome, respectively.  
 
The methylation profile was analysed according to the 
manufacturer’s instructions using Illumina-supplied 
reagents and conditions. In brief, after bisulfite 
conversion, 250 ng of DNA were whole-genome 
amplified (WGA) and enzymatically fragmented. The 
bisulfite-converted WGA-DNA samples were purified 
and randomized again prior to hybridization to 
BeadChips. During hybridization, the WGA-DNA 
molecules annealed to locus-specific DNA oligomers 
linked to individual bead types, one designed against 
the unmethylated site and one against the methylated 
site. After hybridization, allele-specific single-base 
extension provided another level of specificity and 
incorporated a fluorescent label for detection. The level 
of methylation was determined at each locus by the 
intensity of the two possible fluorescent signals, specific 
for the methylated and unmethylated alleles. DNA 
methylation values, described as β- values, were 
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recorded for each locus in each sample. Beta-value 
provides a continuous measure of levels of DNA 
methylation at a CpG site, ranging from 0 in the case of 
completely unmethylated sites to 1 in completely 
methylated sites. 
 
HUMARA assay. X-inactivation pattern was 
determined in 45 female blood DNA samples using a 
modification of the methylation analysis of the 
HUMARA locus as described previously (26- 
GENTILINI). Briefly, 250 ng of DNA were digested at 
37°C for 2 h with 10 U HpaII and 10 U HhaI (CELBIO) 
and a no-enzyme control digest was also setup for each 
sample. Digested and undigested DNAs were then 
amplified in duplicate PCRs using primers, amplifying 
the highly polymorphic CAG repeat region in Exon 1 of 
the AR gene at Xq12. The sequences of the primers 
used were as follows: forward; 5’-GCT GTG AAG GTT 
GCT GTT CCT CAT-3’ labelled with 5’-
phosphoamidite dye, reverse; 5’-TCC AGA ATC TGT 
TCC AGA GCG TGC-3’. The samples were amplified 
for 35 cycles comprising of 15 s at 95°C, 30 s at 62°C 
and 30 s at 72°C with an initial denaturation at 95°C for 
5 min. The PCR products were separated on an ABI 310 
automated sequencer. The size of PCR product from 
each allele was analysed by Genescan software for the 
quantification by peak height. 
 
XCI skewing was measured as Degree of Skewing 
(DS), which designates the percentage of the 
preferentially active allele. DS varies between 0% and 
50%, where 0% indicates a random X inactivation 
pattern and 50% a completely skewed inactivation 
pattern. 
 
Methylation data management, normalisation and 
quality control. Methylation raw data were generated 
using GenomeStudio software (Illumina, San Diego, 
CA)and were pre-processed using IMA R package [23]. 
Samples with low bisulphite conversion (BS) efficiency 
(BS control intensity values < 4000) were immediately 
excluded from the analysis as well as samples that 
failed the quality control analysis performed according 
the IMA package pipeline. Moreover, a principal 
component analysis was performed on methylation data 
in order to identify and remove samples with aberrant 
methylation profiles. A total of 8 samples were 
excluded from the study. Density plot of β-values 
showed a bimodal distribution with a shift between the 
positions of the peaks derived from type I and type II 
assay. Therefore, peak correction was performed using 
the IMA package, moreover data were normalised using 
background correction followed by quantile 
normalisation method. Furthermore, probes containing 
missing β-values, probes having <95% of samples with 
detection p-value <0.05 and probes on chromosome X 
and Y were also removed from the analysis.  
 
We finally pooled data obtained from 27K and from 
450K arrays and created a new data matrix containing 
25.014 probes that were in common between the two 
array platforms and passed quality control steps.  
 
Epimutations detection. The distribution and variability 
of methylation levels in our population were studied for 
each one of the 25.014 CpG sites using Box-and-
whiskers plots in order to identify SEMs. For each 
probe, whenever the methylation level of one subject 
extremely differed from the rest of the population we 
considered the outlier sample as epimutated for that 
locus.  
 
Thus, for each locus epimutated subjects were identified 
as the extreme outliers with methylation level exceeding 
three times interquartile ranges Q1-(3 x IQR) and 
Q3+(3 x IQR).  Finally, all epimutated loci were 
annotated in a new data matrix that allowed to calculate, 
for each subject, the total amount of epimutations and 
their genomic position.  
 
A schematic description of the analysis is shown in 
Figure 2.  
 
The Box-and-whiskers plot analysis was conducted 
using boxplot function provided in the R car package 
and confirmed using the outlier function in the R 
outliers package.  
 
Validation of the SEM analysis. In order to confirm the 
power of this analytical approach to detect epimutations 
we performed two separate tests after introducing 
positive controls.   
 
1) We analysed 3 samples in duplicates and compared 
epimutations found in each of them. Results showed a 
mean correlation of 0.99 p< 0.01 among the 
experiments. It’s important to underlie that the duplicate 
samples underwent independent bisulfite conversion 
reactions and this suggests that epimutations are not 
significantly influenced by bisulfite conversion errors. 
2) We analysed 48 whole blood DNA samples obtained 
from subjects affected by imprinting diseases (BWS 
syndrome, Angelman Syndrome and Silver Russel 
syndrome) that attended diagnostic test at Istituto 
Auxologico Italiano. For these subjects we already had 
a medical report indicating the genomic position of their 
epigenetic alteration. For this control test, we used only 
data obtained from Illumina Infinium 450K arrays thus 
reducing the number of the control population (n=91). 
However, using a more informative array, we were able 
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to better define all probes showing epigenetic 
alterations. Briefly, after the identification of the 
epimutated probes we performed a test for 
overrepresentation of epimutated probes inside each 
gene using the hypergeometric cumulative function. We 
considered the total number of probes (NG = 485.764), 
the total number of epimutated probes in the selected 
sample (NS) the number of probes in each gene (GI) and 
the epimutated probes in each gene (SI).  
 
The analysis identified genes with enriched number of 
epimutated probes (bonferroni corrected p-value < 0.05) 
confirming the presence of the epigenetic alterations 
previously reported in the medical report. 
 
Supplemental Figure 3 shows positive control test 
results. 
 
All the R scripts employed as well as the set of 
methylation data generated will be made freely 
available to the scientific community.  
 
Multiple regression and path analysis. The variables 
(age, BMI, overall methylation level, Skewing of XCI 
and log(SEM))were Z transformed and Z scores were 
used for the multiple regression and path analysis. 
Results of regression analyses were indicated as 
standardised regression coefficients β. 
 
The univariate and multivariate linear regressions were 
conducted using the generalised linear mixed model 
function provided in the R base package.  
 
The interrelationships among skewing of XCI and the 
other variables were examined by a path analysis 
model. A path diagram with associated path coefficients 
(β) was constructed as shown in Figure 4 based on 
previous findings [13] and theoretic rationales.  
 
As age is generally considered a determinant of changes 
in XCI skewing profile and in overall DNA 
methylation, direct and indirect Paths from age to these 
components were tested. The Path Analysis was 
performed using the General Structural Equation 
Models R package.  
 
Missing data imputation. Multiple imputation, 
producing five imputed datasets, was carried out to 
allow full use of all available data. 
 
Imputation was performed using the bootstrap-based 
EMB algorithm included in the R package Amelia II. 
Five imputations were generated and models fitted to 
each imputed dataset. Model results were consolidated 
using Rubin’s rules [43]. 
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Supplemental Figure 3. Validation of the analytical approach. The picture shows a graphic representation
of probes resulted epimutated in samples carrying a previously described epigenetic defect. (A.1) The Figure
describes  a  case  of Beckwith‐Wiedemann  Syndrome.  In  black  the  cohordinates  of  all  probes,  in  red  the
position of CpG island and in blue the genomic position of probes resulted epimutated. (A.2) Magnification
of the region with the epigenetic alteration. (B.1) The Figure describes a case of Silver Russel Syndrome. In
black the cohordinates of all probes,  in red the position of CpG  island and  in blue the genomic position of
probes resulted epimutated. (B.2) Magnification of the region with the epigenetic alteration. 
